| Name | Title | Contact Details |
|---|
Avaxia is a leader in the growing field of gut-targeted therapeutics — orally administered, minimally absorbed drugs that are designed to act locally in the gastrointestinal tract. Avaxia’s lead clinical candidate, AVX-470, is an oral anti-TNF antibody for inflammatory bowel disease. This transformative product offers potentially improved safety and efficacy over existing anti-TNF therapies by focusing immune suppression only where needed in the diseased gut. Avaxia plans to use its gut-targeted antibody platform to develop therapeutics to address many other serious diseases such as type 2 diabetes, celiac disease, GI acute radiation syndrome and oral mucositis.
Blue Cross Blue Shield of Michigan is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Detroit, MI. To find more information about Blue Cross Blue Shield of Michigan, please visit www.bcbsm.com
The Aspen Hope Center is a mental health organization that provides immediate contact to clinical professionals 24/7, information and referral to local mental health services, crisis intervention with a mobile crisis team 24/7, community education abou...
At Ancient Nutrition, our mission is to restore our health, strength and vitality by providing history`s healthiest whole food nutrients to the modern world.
Health One is a Ridgeland, MS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.